I have not traded in and out. I have more than doubled down. I think at this price it's a very good bet. If that makes me arrogant, then you, I surely am.
You're thinking with your emotions here regarding R/R. The financing risks and the risks of failure of the ph 3 trial including the enrollment halt which may or may not be a bad sign, were all very well known when the stock traded at $3 and have not changed. The financings at a low price were always a big risk. The pps getting down here hasn't changed that risk much at all unless you think it was ever realistic to think that they would have very good news between Feb 29 and now, which you adamantly deny.
Price is now 1/6 of what it was in Feb - and yes, price pretty much determines what is at risk, by definition in a microcap biotech binary succeed or die stock. The reward potential of a 1.5B+ mkt cap has not changed except for dilution which is a well known risk. You have to be confused or emotional or both not to get that.
BTW I have never said there is no risk, only that the R/R has changed very drastically. That is objectively measured by pps and news or lack thereof. And 4 months without great news hardly represents a radical change in fundamental outlook in my book. I don't think your complete distrust in management has even changed at all in the last 4 months. I'm pretty sure if I looked back I'd see you were just as negative back in Feb as you are now. I don't think that you are using your head to think about this.
News 
Market Data 
Discover 
